PSivida Says Iluvien Gets Marketing Authorizations In 10 More EU Countries

June 30, 2014 12:16 PM

2 0

pSivida Corp. (PSDV: Quote), Monday said ILUVIEN has been granted marketing authorizations in Belgium, the Czech Republic, Denmark, Finland, Ireland, Luxembourg, the Netherlands, Norway, Poland and Sweden.

This was following the successful completion of the Mutual Recognition Procedure for subsequent authorizations. In the national phase, each of these countries will grant a marketing authorization for Iluvien, which is an injectable, sustained release micro-insert used for the treatment of chronic DM...

Also read: Opinion: Trump risks reigniting Asia's most dangerous flashpoint

Read more

To category page

Loading...